A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg 2018; 68: 1744-1752.
Published: 21st June 2019
Authors: Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B et al.
Use of a vacuum dressing significantly reduced the risk of surgical site infection, particularly in patients at high risk of groin infection after surgery in this study that included 119 incisions.Pubmed Link
You may also be interested in
Management of extremity fasciotomy sites prospective randomized evaluation of two techniques. Am J Surg 2018; 216: 736–739.
Authors: Johnson LS, Chaar M, Ball CG, Perez S, Nicholas JM, Wyrzykowski AD et al.
Closed incision negative pressure therapy reduces surgical site infections in vascular surgery: a prospective randomised trial (AIMS Trial). Eur J Vasc Endovasc Surg 2018; 56: 442-448.
Authors: Gombert A, Babilon M, Barbati ME, Keszei A, von Trotha KT, Jalaie H et al.
Randomized clinical trial of negative pressure wound therapy for high-risk groin wounds in lower extremity revascularization . J Vasc Surg 2017; 66: 1814-1819.
Authors: Lee K, Murphy PB, Ingves MV, Duncan A, DeRose G, Dubois L et al.
Randomized trial of a dry-powder, fibrin sealant in vascular procedures. J Vasc Surg 2015; 62: 1288–1295.
Authors: Gupta NY, Chetter I, Hayes P, O-Yurvati AH, Moneta G, Shenov S et al.
Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization. Ann Surg 2015; 262: 495–501.
Authors: Stone P, AbuRahma, AF, Campbell JR, Hass S, Mousa AY et al.
A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access. J Vasc Surg 2015; 62: 115–122.
Authors: Shemesh D, Goldin I, Hijazi J, Zaghal I, Berelowitz D, Verstandig A et al. et al.
Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. J Vasc Surg 2015; 61: 703–712.
Authors: Lumsden AB, Morrissey NJ, Staffa R, Lindner J, Janousek L, Treska V et al.on behalf of the Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators et al.
Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications. J Vasc Surg 2015; 61: 419–427.
Authors: Ozaki CK, Hamdan AD, Barshes NR, Wyers M, Hevelone MD, Belkin M et al. et al.
A meta-analysis to compare Dacron versus polytetrafluoroethylene grafts for above-knee femoropopliteal bypass. J Vasc Surg 2014; 60: 506-515.
Authors: Rychlik IJ, Davey P, Murphy J, O'Donnell ME
Vaccuum-assisted wound closure versus alginate for the treatment of deep perivascular wound infections in the groin after vascular surgery. J Vasc Surg 2014; 59: 145-151.
Authors: Monsen C, Wann-Hansen C, Wictorsson C, Acosta S
Superior two-year results of externally unsupported polyester compared to supported grafts in above knee bypass grafting: a multicenter randomized trial. Eur J Vasc Endovasc Surg 2013; 45: 275-281.
Authors: Vriens BHR, van Det RJ, Meerwaldt R, van der Palen J, Gerrits DG, Zeebregts CJ et al. et al.
A randomised prospective multicenter trial of novel vascular sealant. Ann Vasc Surg 2012; 26: 1077–1084.
Authors: Stone WM, Cull DL, Money SR